KUALA LUMPUR, June 8 — The Health Ministry (MOH) will start administering treatments with the monoclonal antibody drugs Tixagevimab and Cilgavimab (Evusheld) in the near future to ensure that high-risk groups continue to be protected from Covid-19 infection.
Media Selangor Sdn Bhd, a subsidiary of the Selangor State Government (MBI), is a government media agency. In addition to Selangorkini and SelangorTV, the company also publishes portals and newspapers in Mandarin, Tamil and English.